Catalyst Wire Dossier Catalyst Wire Dossier

N-Acetyl-D-Mannosamine (ManNAc)

N-Acetyl-D-Mannosamine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for N-Acetyl-D-Mannosamine (ManNAc), covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Primary Focal Segmental Glomerulosclerosis [Phase 2]

See pricing